These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 5598332)

  • 21. [Experimental research on the antimitotic action of podophyllinic acid ethylhydrazide on erythropoietic cells].
    Rondanelli R; Magliulo E; Stassano G; Giraldi M
    Arch Sci Med (Torino); 1968 Apr; 125(4):115-21. PubMed ID: 5686613
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of indirubin on hemopoietic cell production (author's transl)].
    Wan JH; You YC; Mi JX; Ying HG
    Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):241-4. PubMed ID: 6462023
    [No Abstract]   [Full Text] [Related]  

  • 23. Parathyroid hormone: a novel tool for treating bone marrow depletion in cancer patients caused by chemotherapeutic drugs and ionizing radiation.
    Whitfield JF
    Cancer Lett; 2006 Nov; 244(1):8-15. PubMed ID: 16540235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral blood and bone marrow changes after treatment with ATRA and G-CSF in AML, APL and blast crisis following Vaquez's disease.
    Notario A; Rolandi ML; Mazzucchelli I
    Haematologica; 1996; 81(3):261-4. PubMed ID: 8767533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Autologous bone marrow grafts and solid tumors].
    Beaulieu R
    Union Med Can; 1983 May; 112(5):450-2, 460. PubMed ID: 6349082
    [No Abstract]   [Full Text] [Related]  

  • 26. Protecting bone marrow by gene therapy.
    Sikora K
    Gene Ther; 1995 Jun; 2(4):233-4. PubMed ID: 7552982
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnosis of bone marrow disorders: is MRT sufficient?].
    Kramer J
    Radiologe; 2007 Aug; 47(8):660-2. PubMed ID: 17721793
    [No Abstract]   [Full Text] [Related]  

  • 28. Improving the interpretation of bone marrow imaging in cancer patients.
    Ollivier L; Gerber S; Vanel D; Brisse H; Leclère J
    Cancer Imaging; 2006 Dec; 6(1):194-8. PubMed ID: 17208675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
    Lopez M; Mary JY; Sainteny F
    Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Observation of bone marrow function in cytostatic treatment of malignant tumors].
    KRATZSCH E; SCHMERMUND HJ
    Med Klin; 1959 Jul; 54(27):1238-40. PubMed ID: 13673975
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of the combination of cytotoxic drugs and x-ray on rat bone marrow. Clinical findings].
    Maisin H
    Acta Clin Belg; 1966; 21(5):302-25. PubMed ID: 5974092
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of 1,2:5,6-dianhydrogalactitol and 1,2:5,6-dianhydro-3,4-diacetylgalactitol on DNA synthesis in the cells of melanoma B16, bone marrow, small intestine epithelium, spleen and liver of mice].
    Sokolova IS; Elekes I; Otvös L; Gorbacheva LB
    Biull Eksp Biol Med; 1984 Sep; 98(9):301-3. PubMed ID: 6487788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Allogeneic stem cell transplantation. A valuable alternative after myeloablative chemotherapy].
    Unterhuber R
    Fortschr Med; 1996 May; 114(14):175-6. PubMed ID: 8707236
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention of infections in radiation and cytostatic depression of the bone marrow].
    Nadezhina NM; Petrosian LN; Selidovkin GD; Baranov AE
    Med Radiol (Mosk); 1982 Nov; 27(11):32-9. PubMed ID: 6757630
    [No Abstract]   [Full Text] [Related]  

  • 35. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy.
    Ledzewicz U; Schättler H
    Math Biosci; 2007 Apr; 206(2):320-42. PubMed ID: 16197967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe, prolonged bone marrow hypoplasia secondary to the use of carboplatin in an azotemic dog.
    Phillips B
    J Am Vet Med Assoc; 1999 Nov; 215(9):1250-2; discussion 1252-3. PubMed ID: 10553432
    [No Abstract]   [Full Text] [Related]  

  • 37. [The blood-simulating properties of a recombinant colony-stimulating factor and glycyram during cytostatic myelosuppression].
    Dygaĭ AM; Zhdanov VV; Masycheva VI; Minakova MIu; Romanov VP; Pustoshilova NM; Simanina EV; Agafonov VI; Gol'dberg ED
    Eksp Klin Farmakol; 1999; 62(1):34-7. PubMed ID: 10198763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic problems in follow-up bone marrow biopsies of patients treated for acute and chronic leukaemias and MDS.
    Dirnhofer S; Went P; Tichelli A
    Pathobiology; 2007; 74(2):115-20. PubMed ID: 17587882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion chamber cultures of bone marrow cells in refractory anemia with excess oil blasts (RAEB).
    Izzi T; Fontebuoni A; Talevi N; Lucarelli G
    Haematologica; 1981 Oct; 66(5):570-8. PubMed ID: 6796466
    [No Abstract]   [Full Text] [Related]  

  • 40. The protection against trimetrexate cytotoxicity in human bone marrow by sequence-dependent administration of raloxifene, 5-fluorouracil/trimetrexate.
    Das JR; Fryar EB; Green S; Southerland WM; Bowen D
    Anticancer Res; 2006; 26(6B):4279-86. PubMed ID: 17201145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.